Bellerophon Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
26,079.00
24,067.00
20,174.00
32,221.00
16,746
Other Current Assets
1,552.00
1,602.00
5,385.00
6,331.00
3,359.00
650
Total Current Assets
1,552.00
27,681.00
29,452.00
26,505.00
35,580.00
17,396
Net Property, Plant & Equipment
2,084.00
1,696.00
1,799.00
1,399.00
1,026.00
664
Total Investments and Advances
-
1,548.00
457.00
307.00
150.00
300
Other Assets
-
2,466.00
6,701.00
1,491.00
54.00
-
Total Assets
3,636.00
33,391.00
38,409.00
29,702.00
36,810.00
18,360
Accounts Payable
-
-
-
2,807.00
3,853.00
Other Current Liabilities
13,992.00
10,454.00
8,073.00
3,688.00
3,226.00
Total Current Liabilities
13,992.00
10,454.00
8,073.00
6,495.00
7,079.00
Provision for Risks & Charges
-
-
-
5,215.00
32,325.00
Other Liabilities
5,381.00
-
-
-
-
Total Liabilities
19,373.00
10,454.00
8,073.00
11,710.00
39,404.00
Common Equity (Total)
15,737.00
22,937.00
30,336.00
17,992.00
2,594.00
Total Shareholders' Equity
15,737.00
22,937.00
30,336.00
17,992.00
2,594.00
Total Equity
15,737.00
22,937.00
30,336.00
17,992.00
2,594.00
Liabilities & Shareholders' Equity
3,636.00
33,391.00
38,409.00
29,702.00
36,810.00
About Bellerophon Therapeutics
View Profile
